Cargando…

Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification

Stigma and discrimination continue to be a reality in the lives of people suffering from mental illness, particularly schizophrenia, and prove to be one of the greatest barriers to regaining a normal lifestyle and health. Research advances have defined stigma and assessed its implications and have e...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrivastava, Amresh, Bureau, Yves, Rewari, Nitika, Johnston, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696244/
https://www.ncbi.nlm.nih.gov/pubmed/23825855
http://dx.doi.org/10.4103/0019-5545.111459
_version_ 1782476307132579840
author Shrivastava, Amresh
Bureau, Yves
Rewari, Nitika
Johnston, Megan
author_facet Shrivastava, Amresh
Bureau, Yves
Rewari, Nitika
Johnston, Megan
author_sort Shrivastava, Amresh
collection PubMed
description Stigma and discrimination continue to be a reality in the lives of people suffering from mental illness, particularly schizophrenia, and prove to be one of the greatest barriers to regaining a normal lifestyle and health. Research advances have defined stigma and assessed its implications and have even examined intervention strategies for dealing with stigma. We are of the opinion that stigma is a potential clinical risk factor. It delays treatment seeking, worsens course and outcome, reduces compliance, and increases the risk of relapse; causing further disability, discrimination, and isolation even in persons who have accessed mental health services. The delay in treatment due to stigma causes potential complications like suicide, violence, harm to others, and deterioration in capacity to look after one's physical health. These are preventable clinical complications. In order to deal with the impact of stigma on an individual basis, it needs to be (i) assessed during routine clinical examination, (ii) assessed for quantification in order to obtain measurable objective deliverables, and (iii) examined if treatment can reduce stigma and its impact on individuals. New and innovative anti-stigma programs are required that are clinically driven in order to see the change in life of an individual by removing potential risks. The basic requirement for dealing with an individual's stigma perception/experience is its proper assessment for origin and impact in both a qualitative and quantitative manner. We further argue that quantification would allow for regular assessment and offer more effective intervention for patients. It will also be helpful in identifying modifiable social factors to enhance quality of care planning for management in hospitals and communities. The objective of quantification is to facilitate developing an approach to bring the assessment of stigma into clinical work and formulating customized strategies to deal with stigma at the patient level. It would be expected that the assessment of stigma would become a part of routine clinical assessment to identify barriers to outcome. This article discusses the need for quantification of patients’ experiences of mental illness stigma.
format Online
Article
Text
id pubmed-3696244
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36962442013-07-03 Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification Shrivastava, Amresh Bureau, Yves Rewari, Nitika Johnston, Megan Indian J Psychiatry Current Theme Stigma and discrimination continue to be a reality in the lives of people suffering from mental illness, particularly schizophrenia, and prove to be one of the greatest barriers to regaining a normal lifestyle and health. Research advances have defined stigma and assessed its implications and have even examined intervention strategies for dealing with stigma. We are of the opinion that stigma is a potential clinical risk factor. It delays treatment seeking, worsens course and outcome, reduces compliance, and increases the risk of relapse; causing further disability, discrimination, and isolation even in persons who have accessed mental health services. The delay in treatment due to stigma causes potential complications like suicide, violence, harm to others, and deterioration in capacity to look after one's physical health. These are preventable clinical complications. In order to deal with the impact of stigma on an individual basis, it needs to be (i) assessed during routine clinical examination, (ii) assessed for quantification in order to obtain measurable objective deliverables, and (iii) examined if treatment can reduce stigma and its impact on individuals. New and innovative anti-stigma programs are required that are clinically driven in order to see the change in life of an individual by removing potential risks. The basic requirement for dealing with an individual's stigma perception/experience is its proper assessment for origin and impact in both a qualitative and quantitative manner. We further argue that quantification would allow for regular assessment and offer more effective intervention for patients. It will also be helpful in identifying modifiable social factors to enhance quality of care planning for management in hospitals and communities. The objective of quantification is to facilitate developing an approach to bring the assessment of stigma into clinical work and formulating customized strategies to deal with stigma at the patient level. It would be expected that the assessment of stigma would become a part of routine clinical assessment to identify barriers to outcome. This article discusses the need for quantification of patients’ experiences of mental illness stigma. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3696244/ /pubmed/23825855 http://dx.doi.org/10.4103/0019-5545.111459 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Current Theme
Shrivastava, Amresh
Bureau, Yves
Rewari, Nitika
Johnston, Megan
Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification
title Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification
title_full Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification
title_fullStr Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification
title_full_unstemmed Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification
title_short Clinical risk of stigma and discrimination of mental illnesses: Need for objective assessment and quantification
title_sort clinical risk of stigma and discrimination of mental illnesses: need for objective assessment and quantification
topic Current Theme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696244/
https://www.ncbi.nlm.nih.gov/pubmed/23825855
http://dx.doi.org/10.4103/0019-5545.111459
work_keys_str_mv AT shrivastavaamresh clinicalriskofstigmaanddiscriminationofmentalillnessesneedforobjectiveassessmentandquantification
AT bureauyves clinicalriskofstigmaanddiscriminationofmentalillnessesneedforobjectiveassessmentandquantification
AT rewarinitika clinicalriskofstigmaanddiscriminationofmentalillnessesneedforobjectiveassessmentandquantification
AT johnstonmegan clinicalriskofstigmaanddiscriminationofmentalillnessesneedforobjectiveassessmentandquantification